Update: MFTH has exploded out of triple zero land in recent trading sessions on massive volume and is quickly gaining the interest of investors.

On April 25, MFTH announced that the Company has filed the necessary corporate action form for the dividend distribution to its shareholders with FINRA and which is currently under review at FINRA.

To find out the inside scoop on MFTH subscribe to OTCMagic.com right now. Also everyone should know, we have something HUGE coming!

______________________________

Penny Stock speculators looking for explosive gains have long turned to Sub Penny Stocks for their ability to make Monster moves in short time frames. One Sub Penny that is getting big attention the last few trading sessions is Medisafe 1 Technologies, Inc (OTC: MFTH) which has made a spectacular run in the last 2 weeks from lows of $0.001 to a recent high of $0.006

While MFTH a developer of patented technologies that physically prevent unauthorized administration of prescription medications has already moved 500% + in recent sessions many believers in the company will tell you it’s just getting started! Much of the excitement surrounds the huge developments and press coming from Medisafe 1 Technologies.

On July 16 they announced that the company has of July 16 2012 acquired 3,100,000 shares of MFTH under the Buyback Program which was authorized by the Board of Directors in June. Under the program, Medisafe 1 Technologies is authorized to repurchase up to 10 million of its outstanding shares of common stock at a price up to $0.10 per share on the open market.

On August 30 they announced that the company is in advanced negotiations to enter into a non-exclusive perpetual license agreement to transfer rights for the full commercialization, marketing and distribution of its patented medicinal locking mechanism and bar-code matching system. Terms of the sale include a one-time payment of $7MM. The perpetual license agreement is anticipated to be signed within 60 days, pending the results of a due diligence study by the intended buyer.

"We hope to soon announce the closing of the perpetual license sale, which will enable the wider distribution of our technology, and to fulfill the principles of our business plan," said Jacob Elhadad, CEO of Medisafe 1 Technologies Corp. "The sale, if completed will infuse Medisafe with much needed capital to further develop and market our proprietary, life-saving devices."

Finally yesterday MFTH announced that the company intends to issue a one-time special dividend to all existing shareholders pending the perpetual license sale of technology rights to a third party. The estimated dividend amount payable to each shareholder of one common stock is $0.01. "Upon the anticipated completion of this non-exclusive perpetual license agreement, we will be extremely pleased to be able to reward our shareholders with this special dividend," said Jacob Elhadad, CEO of Medisafe 1 Technologies Corp. "Similarly; we intend to continue to update our shareholders with further information following the sale's closing."

The dividend is significant because currently the stock trades for less than half a cent meaning shareholders would earn a 200% premium pending the $7MM perpetual license sale of technology rights to a third party.

Conclusion: MFTH has seen some very important developments over the last few months and the investment community is starting to take notice. Currently trading at a market valuation of around $2M MFTH is rapidly starting to develop the type of loyal investor following that catapulted CBIS to 2,000% + gains. All this Makes MFTH a stock to watch and might just provide a spectacular trade opportunity in the weeks and months ahead!

Please subscribe to OTCMagic.com right now!

Medisafe 1 Technologies Corp.

Jacob Elhadad

Yisrael Gottlieb

medisafe1.com

STOCK INFORMATION

SYMBOL: OTC: MFTH

Shares Outstanding 325,864,945

Market Cap: $2,020,363

Medisafe 1 Technologies was incorporated in Delaware on July 7, 2009. On July 15, 2009 they entered into an exclusive worldwide patent sale agreement with the company’s founders and sole officers Yisrael Elhadad and Yisrael Gottlieb. Pursuant to this agreement MFTH purchased Patent Number: 7,347,841 which relates to a medical assembly and a protector, or locking mechanism that is intended to ensure that no substances can be released from the hypodermic needle without positive pre-matching between the substance and the specific patient.

This patent remains the cornerstone of Medisafe 1 Technologies business. The technology has the potential to be adopted as a standard in all major markets, making a decisive contribution towards the elimination of errors from inject able medication. The Patent was acquired by us in exchange for the payment to Yisrael Elhadad and Yisrael Gottlieb of US $100,000.

The Medisafe 1 Technologies Corporation invention, based on the Patent, is a medical assembly which may effectively prevent unauthorized administration of a drug or medicinal substance by hypodermic needle. It accomplishes this by taking a medical assembly and incorporating a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and the specific patient, identified by bar-coding or other identification technology. Since some human interaction will be required in the labeling, administering, and using the intended device, Medisafe 1 cannot entirely remove the risk of human error. It is expected that the system can be applied not only to hypodermic needles, but also to any assembly for storing any kind of medicine.

The Company has developed a fully operational working valid prototype with PIA Electronics Ltd and has agreed to pay PIA Electronics a commission based upon sales revenue in the amount of 10% of all future royalties from the sale and / or licensing of the technology which is based on the working prototype manufactured by PIA Electronics Ltd. To date, no products encompassing the patented technology have been sold.